Filter News
Area of Research
- Biological Systems (1)
- Biology and Environment (16)
- Computational Biology (2)
- Computational Engineering (1)
- Energy Science (6)
- Fusion and Fission (1)
- Isotopes (6)
- Materials (7)
- Materials for Computing (2)
- National Security (2)
- Neutron Science (14)
- Nuclear Science and Technology (2)
- Supercomputing (17)
News Topics
- (-) Biomedical (72)
- 3-D Printing/Advanced Manufacturing (142)
- Advanced Reactors (40)
- Artificial Intelligence (124)
- Big Data (77)
- Bioenergy (109)
- Biology (125)
- Biotechnology (36)
- Buildings (73)
- Chemical Sciences (84)
- Clean Water (32)
- Composites (33)
- Computer Science (223)
- Coronavirus (48)
- Critical Materials (29)
- Cybersecurity (35)
- Education (5)
- Element Discovery (1)
- Emergency (4)
- Energy Storage (114)
- Environment (217)
- Exascale Computing (64)
- Fossil Energy (8)
- Frontier (62)
- Fusion (65)
- Grid (73)
- High-Performance Computing (128)
- Hydropower (12)
- Irradiation (3)
- Isotopes (62)
- ITER (9)
- Machine Learning (66)
- Materials (156)
- Materials Science (155)
- Mathematics (12)
- Mercury (12)
- Microelectronics (4)
- Microscopy (56)
- Molten Salt (10)
- Nanotechnology (62)
- National Security (85)
- Neutron Science (169)
- Nuclear Energy (121)
- Partnerships (66)
- Physics (68)
- Polymers (34)
- Quantum Computing (52)
- Quantum Science (88)
- Security (30)
- Simulation (64)
- Software (1)
- Space Exploration (26)
- Statistics (4)
- Summit (70)
- Transportation (102)
Media Contacts

Oak Ridge National Laboratory will partner with Cincinnati Children’s Hospital Medical Center to explore ways to deploy expertise in health data science that could more quickly identify patients’ mental health risk factors and aid in

A select group gathered on the morning of Dec. 20 at the Department of Energy’s Oak Ridge National Laboratory for a symposium in honor of Liane B. Russell, the renowned ORNL mammalian geneticist who died in July.

Using artificial neural networks designed to emulate the inner workings of the human brain, deep-learning algorithms deftly peruse and analyze large quantities of data. Applying this technique to science problems can help unearth historically elusive solutions.

OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.


OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.
![Coexpression_hi-res_image[1].jpg Coexpression_hi-res_image[1].jpg](/sites/default/files/styles/list_page_thumbnail/public/Coexpression_hi-res_image%5B1%5D_0.jpg?itok=OnLe-krT)
While studying the genes in poplar trees that control callus formation, scientists at Oak Ridge National Laboratory have uncovered genetic networks at the root of tumor formation in several human cancers.

To learn more about interactions between drug molecules and micelles, Associate Professor Megan Robertson and graduate students Tyler Cooksey and Tzu-Han Li from the University of Houston (UH) are using neutrons at the Department of Energy’s (DOE’s) Oak Ridge National Laboratory (ORNL).
![2018-P07635 BL-6 user - Univ of Guelph-6004R_sm[2].jpg 2018-P07635 BL-6 user - Univ of Guelph-6004R_sm[2].jpg](/sites/default/files/styles/list_page_thumbnail/public/2018-P07635%20BL-6%20user%20-%20Univ%20of%20Guelph-6004R_sm%5B2%5D.jpg?itok=DUdZNt_q)
A team of scientists, led by University of Guelph professor John Dutcher, are using neutrons at ORNL’s Spallation Neutron Source to unlock the secrets of natural nanoparticles that could be used to improve medicines.

The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.